Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00129.2014PMID 25015963PMCID PMC4187393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory cytokines in chronic heart failure: interleukin‐8 is associated with adverse outcome. Results from CORONA

  2014cited by this paper
• Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study

  2013cited by this paper
• Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling

  2012cited by this paper
• Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions.

  2012cited by this paper
• Thymosin β4 inhibits TNF‐α‐induced NF‐κB activation, IL‐8 expression, and the sensitizing effects by its partners PINCH‐1 and ILK

  2011cited by this paper
• Subacute Inflammatory Activation in Subjects with Acute Coronary Syndrome and Left Ventricular Dysfunction

  2011cited by this paper
• Thymosin β4: structure, function, and biological properties supporting current and future clinical applications

  2010cited by this paper
• Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).

  2010cited by this paper
• Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

  2010cited by this paper
• Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.

  2009cited by this paper
• Age-related differences in postinfarct left ventricular rupture and remodeling.

  2008cited by this paper
• The immune system and cardiac repair.

  2008cited by this paper
• Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.

  2008cited by this paper
• Thymosin β4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell–Mediated Cardioprotection

  2008cited by this paper
• Development of Thymosin β4 for Treatment of Patients with Ischemic Heart Disease

  2007cited by this paper
• Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization

  2007cited by this paper
• Development of thymosin beta4 for treatment of patients with ischemic heart disease.

  2007cited by this paper
• Role of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in the Antifibrotic and Anti-Inflammatory Effects of the Angiotensin-Converting Enzyme Inhibitor Captopril in Hypertension

  2007cited by this paper
• Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice.

  2006cited by this paper
• Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.

  2006cited by this paper
• Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.

  2006cited by this paper
• ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.

  2005cited by this paper
• Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.

  2005cited by this paper
• Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

  2005cited by this paper
• Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart Failure After Myocardial Infarction

  2004cited by this paper
• Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.

  2004cited by this paper
• Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

  2004cited by this paper
• Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.

  2004cited by this paper
• A mechanistic role for cardiac myocyte apoptosis in heart failure.

  2003cited by this paper
• Angiogenesis in ischemic and neoplastic disorders.

  2003cited by this paper
• Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury.

  2002cited by this paper
• Live or let die: the cell's response to p53

  2002cited by this paper
• The inflammatory response in myocardial infarction.

  2002cited by this paper
• Cardiac Rupture in Acute Myocardial Infarction: A Reassessment

  2002cited by this paper
• Myocardial Infarction and Cardiac Remodelling in Mice

  2002cited by this paper
• Interplay of antibody and T cell responses in acute myocardial infarction.

  2001cited by this paper
• Long-Term Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on Left Ventricular Collagen Deposition in Rats With 2-Kidney, 1-Clip Hypertension

  2001cited by this paper
• Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.

  2000cited by this paper
• Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart.

  2000cited by this paper
• Thymosin β4 Accelerates Wound Healing

  1999cited by this paper
• ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-alpha secretion.

  1999cited by this paper
• Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

  1999cited by this paper
• Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

  1999cited by this paper
• Thymosin beta4 accelerates wound healing.

  1999cited by this paper
• Angiogenesis in Cardiovascular Disease

  1999cited by this paper
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.

  1999cited by this paper
• Echocardiographic assessment of cardiac function in conscious and anesthetized mice.

  1999cited by this paper
• Angiogenesis in cardiovascular disease: current status and therapeutic potential.

  1999cited by this paper
• Biodistribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice.

  1997cited by this paper
• Apoptosis in human acute myocardial infarction.

  1997cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53.

  1997cited by this paper
• Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart.

  1996cited by this paper
• Relevance of electrocardiographic findings, heart failure, and infarct site in assessing risk and timing of left ventricular free wall rupture during acute myocardial infarction.

  1995cited by this paper
• Histopathological study of cardiac rupture following myocardial infarction with and without thrombolytic therapy.

  1994cited by this paper
• Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases.

  1990cited by this paper
• Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units.

  1989cited by this paper
• A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

  1986cited by this paper

• Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity.

  2026cites this paper
• Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals

  2025cites this paper
• Expression levels of thymosin α1 in acute myocardial infarction patients and its correlation to cardiac function

  2025cites this paper
• Ac-SDKP and eplerenone confer additive cardioprotection against angiotensin II-induced cardiac injury in C57BL/6J mice

  2025cites this paper
• Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity

  2025cites this paper
• Ac-SDKP attenuates ER stress-stimulated collagen production in cardiac fibroblasts by inhibiting CHOP-mediated NF-κB expression

  2024cites this paper
• Physiological and Pathophysiological Prerequisites for the Reparative Potential of the Epicardium

  2024cites this paper
• Proteomic analysis of plasma proteins from patients with cardiac rupture after acute myocardial infarction using TMT-based quantitative proteomics approach

  2024cites this paper
• Association of serum thymosin β4 with malnutrition-inflammation-atherosclerosis syndrome in peritoneal dialysis patients: a cross-sectional study

  2023cites this paper
• ScRNA-seq and spatial transcriptomics: exploring the occurrence and treatment of coronary-related diseases starting from development

  2023cites this paper
• Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction

  2023cites this paper
• Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.

  2023cites this paper
• Promoting effect of Tmsb4x on the differentiation of peripheral blood mononuclear cells to dendritic cells during septicemia.

  2022cites this paper
• Knockout of ACE-N facilitates improved cardiac function after myocardial infarction

  2022cites this paper
• Thymosin β4 and actin: binding modes, biological functions and clinical applications.

  2022cites this paper
• The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis

  2022cites this paper
• Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

  2022cites this paper
• Thymosin β4 protect against LPS induced lung injury and inflammation and subsequent fibrosis in mice

  2021cites this paper
• Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation

  2021cites this paper
• Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies

  2021cites this paper
• Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium

  2021cites this paper
• MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.

  2019cites this paper
• Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

  2019cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

  2019cites this paper
• Draft 1 AC-SDKP treatment protects heart against excessive myocardial injury and heart failure in mice

  2019cites this paper
• Thymosin 4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

  2019cites this paper
• Thymosin-β4: A key modifier of renal disease

  2018cites this paper
• Thymosin &bgr;4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II–Induced Hypertension

  2018cites this paper
• Synthesis and Biological Activity of Thymosin β4-Anionic Boron Cluster Conjugates.

  2018cites this paper
• Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease

  2018cites this paper
• Thymosin β4-mediated protective effects in the heart

  2018cites this paper
• Thymosin β4 suppresses CCl4‐induced murine hepatic fibrosis by down‐regulating transforming growth factor β receptor‐II

  2018cites this paper
• Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction

  2018cites this paper
• Endothelial progenitor cell ( EPC ) transplantation improves myocardial infarction via up-regulation of vascular endothelial growth factor and gap junction protein connexin 43 in rats

  2018cites this paper
• Essential role for smooth muscle cell stromal interaction molecule-1 in myocardial infarction

  2018cites this paper
• No effect of thymosin beta‐4 on the expression of the transcription factor Islet‐1 in the adult murine heart

  2018cites this paper
• IRAK3 gene silencing prevents cardiac rupture and ventricular remodeling through negative regulation of the NF‐κB signaling pathway in a mouse model of acute myocardial infarction

  2018influential citation
• In Vivo Reprogramming in Regenerative Medicine

  2017influential citation
• In Vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration

  2017cites this paper
• Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice

  2017cites this paper
• Implantation of a Poly-l-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction

  2017cites this paper
• Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles

  2017cites this paper
• Investigating interactions between rat adult cardiac myocytes and fibroblasts in the heart

  2017cites this paper
• Cardioprotection by Thymosin Beta 4.

  2016cites this paper
• Loss of endogenous thymosin β4 accelerates glomerular disease

  2016cites this paper
• Thymosin beta 4 treatment improves left ventricular function after myocardial infarction and is related to Up-regulation of chitinase 3-like-1 in mice

  2016cites this paper
• glomerular disease Loss of endogenous thymosin b 4 accelerates

  2016cites this paper
• Thymosin β4 Prevents Angiotensin II‐Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling

  2016cites this paper
• Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction

  2015cites this paper
• C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.

  2015cites this paper
• The role of thymosin-β4 in kidney disease

  2015cites this paper